Datta Anita, Sinclair D Barry
Comprehensive Epilepsy Program, University of Alberta, Edmonton, Alberta, Canada.
Pediatr Neurol. 2007 Mar;36(3):141-5. doi: 10.1016/j.pediatrneurol.2006.12.003.
Clinical course and outcome were compared for 126 children with typical and atypical features of benign epilepsy of childhood with rolandic spikes (BECRS). A retrospective case series design was used, in the setting of a tertiary-care pediatric hospital. The subjects were subdivided into two groups, based on clinical presentation. Group A comprised children with typical features of BECRS (n = 66; 52%) and Group B, those with atypical features (n = 60; 48%). Patients' charts were reviewed for demographic data, family history, comorbid conditions, atypical clinical features, anti-epileptic drugs, and outcome data. Comorbid disorders (e.g., attention deficit hyperactivity disorder, behavioral problems) were slightly more frequent in the atypical group. Overall, there was no difference between the time to become seizure free between the groups: by two years, 41 of 66 in Group A (62%) and 44 of 60 in Group B (71%) were controlled on medication and seizure free. Twenty of the 126 children (16%) required trial of a second anti-epileptic drug: 7 in Group A and 13 in Group B. Resolution of the epilepsy occurred in about the same length of time in both groups (but at different ages, consistent with different age of onset). Both groups had similar long-term outcome.
对126例具有罗兰多棘波的儿童良性癫痫(BECRS)典型和非典型特征的患儿的临床病程和转归进行了比较。采用回顾性病例系列设计,研究地点为一家三级儿科医院。根据临床表现将研究对象分为两组。A组包括具有BECRS典型特征的儿童(n = 66;52%),B组为具有非典型特征的儿童(n = 60;48%)。查阅患者病历以获取人口统计学数据、家族史、合并症、非典型临床特征、抗癫痫药物及转归数据。非典型组的合并症(如注意力缺陷多动障碍、行为问题)略多。总体而言,两组达到无癫痫发作的时间无差异:两年时,A组66例中有41例(62%)、B组60例中有44例(71%)通过药物治疗得到控制且无癫痫发作。126例患儿中有20例(16%)需要试用第二种抗癫痫药物:A组7例,B组13例。两组癫痫缓解发生的时间大致相同(但年龄不同,这与起病年龄不同一致)。两组的长期转归相似。